Drug Shortage Report for XYLOCAINE 2% W EPINEPHRINE 1:200000

Last updated on 2024-04-21 History
Report ID 222670
Drug Identification Number 00284106
Brand name XYLOCAINE 2% W EPINEPHRINE 1:200000
Common or Proper name lidocaine HCI 2% w/epin. 1:200M 10x20mL SU Vial
Company Name ASPEN PHARMACARE CANADA INC.
Market Status MARKETED
Active Ingredient(s) EPINEPHRINE LIDOCAINE HYDROCHLORIDE
Strength(s) 5MCG 20MG
Dosage form(s) SOLUTION
Route of administration EPIDURAL EPIDURAL
Packaging size 10 vials
ATC code N01BB
ATC description ANESTHETICS, LOCAL
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2024-04-20
Actual start date
Estimated end date 2024-07-31
Actual end date
Shortage status Actual shortage
Updated date 2024-04-21
Company comments VR44557CA1 XYLOCAIN AD20MG:5MCG/ML SDV10X20ML CA AS
Health Canada comments
Tier 3 Status No
Contact Address UNIT 8, 1155 NORTH SERVICE ROAD WEST
OAKVILLE, ONTARIO
CANADA L6M 3E3
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2024-04-21 English Compare
v7 2024-04-15 French Compare
v6 2024-04-15 English Compare
v5 2024-04-03 French Compare
v4 2024-04-03 English Compare
v3 2024-04-02 English Compare
v2 2024-03-18 French Compare
v1 2024-03-18 English Compare

Showing 1 to 8 of 8